On February 29, 2024, the House Energy and Commerce Committee Health Subcommittee held a hearing to discuss several pieces of legislation related to rare diseases. Representatives and witnesses agreed that more needs to be done to ensure Americans with rare diseases have access to innovative treatments at an affordable price.
Menu